About

About Celliaz

Pioneering Retinal
Regeneration

Restoring Vision Through Regenerative Science

Celliaz is a biotechnology company developing
next-generation regenerative therapeutics
for retinal degenerative diseases.

Founded on breakthrough discoveries from KAIST research,
Celliaz is pioneering innovative approaches to restore vision
by unlocking the regenerative potential of damaged
retinal tissue and ultimately restoring lost vision.

About Celliaz

Pioneering Retinal
Regeneration

Restoring Vision Through
Regenerative Science

Celliaz is a biotechnology company developing next-generation regenerative therapeutics for retinal degenerative diseases.

Founded on breakthrough discoveries
from KAIST research, Celliaz is pioneering innovative approaches to restore vision
by unlocking the regenerative potential of damaged retinal tissue and ultimately
restoring lost vision.

Core Competencies

Vision Restoration

Moving beyond symptom control
to vision restoration through
retinal regeneration.

Innovation

Developing first-in-class
therapies that remove biological
arriers to retinal repair.

Universal Applicability

Targeting regenerative
mechanisms rather than
individual mutations

Global Opportunity

Creating scalable regenerative therapies for patients worldwide.

Core Competencies

Vision Restoration

Moving beyond symptom control
to vision restoration through
retinal regeneration.

Innovation

Developing first-in-class
therapies that remove biological
arriers to retinal repair.

Universal Applicability

Targeting regenerative
mechanisms rather than
individual mutations

Global Opportunity

Creating scalable regenerative
therapies for patients worldwide.

Our Vision for the Future

A new Paradigm for
Vision Recovery

Celliaz is advancing a new generation of regenerative therapeutics
designed to restore vision rather than merely delay its loss.

Building on proprietary discoveries in retinal regeneration,
we continue to expand our platform technologies,
strengthen global partnerships, and accelerate the path toward clinical
development and commercialization.

Our Vision for the Future

A new Paradigm for
Vision Recovery

Celliaz is advancing a new generation
of regenerative therapeutics designed
to restore vision rather than merely delay its loss.

Building on proprietary discoveries
in retinal regeneration,
we continue to expand our platform technologies, strengthen global partnerships, and accelerate the path toward clinical development and commercialization.

CREATING A NEW THERAPEUTIC
PARADIGM FOR DEGENERATIVE DISEASES

Tissue Regeneration
By Homeoprotein Targeting Therapies.